National Association of Chain Drug Stores
FDANonrulemakingFDA-2013-D-1543

Nonproprietary Naming of Biological Products

RIN
Last modified
May 28, 2019
Comment window
closed 2639d ago
National Association of Chain Drug Stores filings
3

Activity

National Association of Chain Drug Stores filed 3 comments on this docket between Oct 29, 2015 and May 9, 2019. 58 other organizations filed here. The comment window closed 2639d ago.

What National Association of Chain Drug Stores filed (3)

May 9, 2019· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2013-D-1543-0239

Please see the attached comments of the National Association of Chain Drug Stores (NACDS) on the draft guidance outlining the updated policy of the Food and Drug Administration (FDA) on Nonproprietary Naming of Biological Products. NACDS appreciates FDA considering our feedback on this matter.

Oct 29, 2015· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2013-D-1543-0144

Please see the attached comments of the National Association of Chain Drug Stores on the draft guidance entitled "Nonproprietary Naming of Biological Products." We appreciate FDA considering our input on this matter.

Oct 29, 2015· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2013-D-1543-0164

Please see the attached comments of the National Association of Chain Drug Stores. We appreciate FDA considering our input on this matter.

Abstract

No abstract recorded.

View on regulations.gov →
Nonproprietary Naming of Biological Products (FDA) — National Association of Chain Drug Stores | OpenPolis